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ABSTRACT The posttranslational modification of carboxy-terminal tails of tubulin plays an 
important role in the regulation of the microtubule cytoskeleton. Enzymes responsible for 
deglutamylating tubulin have been discovered within a novel family of mammalian cytosolic 
carboxypeptidases. The discovery of these enzymes also revealed the existence of a range of 
other substrates that are enzymatically deglutamylated. Only four of six mammalian cytosolic 
carboxypeptidases had been enzymatically characterized. Here we complete the functional 
characterization of this protein family by demonstrating that CCP2 and CCP3 are deglutamy-
lases, with CCP3 being able to hydrolyze aspartic acids with similar efficiency. Deaspartyla-
tion is a novel posttranslational modification that could, in conjunction with deglutamylation, 
broaden the range of potential substrates that undergo carboxy-terminal processing. In ad-
dition, we show that CCP2 and CCP3 are highly regulated proteins confined to ciliated tis-
sues. The characterization of two novel enzymes for carboxy-terminal protein modification 
provides novel insights into the broadness of this barely studied process.
INTRODUCTION
Microtubules (MTs) are dynamic, polarized polymers composed of 
α/β-tubulin heterodimers and constitute the largest filaments of 
the cytoskeleton (reviewed in Akhmanova and Steinmetz, 2008). 
MTs take part in a variety of cellular structures and functions in 
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eukaryotic cells, such as cell shape and motility (reviewed in 
Etienne-Manneville, 2004), intracellular organization, and trans-
port (reviewed in de Forges et al., 2012). Moreover, MTs are the 
key structures of complex organelles such as centrioles (reviewed 
 http://www.molbiolcell.org/content/suppl/2014/08/04/mbc.E14-06-1072.DC1.html
Supplemental Material can be found at: 
3018 | O. Tort et al. Molecular Biology of the Cell
a standard nomenclature (Schechter and Berger, 1967). Accord-
ingly, substrate residues are indicated as –P3–P2–P1↓P1′, where 
P1′ is the C-terminal substrate residue to be cleaved, and the cor-
responding binding subsites in the carboxypeptidase are named 
S3, S2, S1, and S1′ (Figure 1B). In the structural models of hCCP2 
and hCCP3, an arginine (Arg) at position 255 (numbering accord-
ing to active bovine carboxypeptidase A1 [CPA1; PDB 3HLP]), at 
the base of the S1′ subsite or specificity pocket, appears to be 
critical in determining the substrate preference of these enzymes 
(Figure 1A). In metallocarboxypeptidases, the residue at position 
255 directly interacts with the C-terminal side chain of the sub-
strates (reviewed in Arolas et al., 2007; Fernández et al., 2010). A 
basic amino acid in this position suggest that hCCP2 and hCCP3 
should have a preference for acidic amino acids, similar to car-
boxypeptidase O (Wei et al., 2002; Lyons and Fricker, 2011). 
Sequence alignment of human and murine CCPs predicts that 
Arg-255 is conserved in all six CCPs (Supplemental Figure S1B). 
Moreover, a lysine or arginine (Lys/Arg-250) close to Arg-255 is 
also conserved in the specificity pocket of CCPs and may contrib-
ute to their preference for acidic amino acids (Figure 1A and Sup-
plemental Figure S1B).
In the hCCP2 and hCCP3 models, the entrance to the active site 
presents an extended positively charged area, which is similarly 
formed by conserved residues throughout all CCPs and can be as-
sociated with different binding subsites of these enzymes (Figure 1C 
and Supplemental Figure S1C). The positively charged area around 
the active site of CCPs explains their preference for substrates with 
long polyglutamate chains, such as polyglutamylated tubulin 
(Rogowski et al., 2010; Berezniuk et al., 2012; Wu et al., 2012). In 
particular, positively charged amino acids in the S1 subsite are con-
sistent with binding of glutamic acids present at the P1 position of 
deTyr-tubulin. In addition, the hCCP2/3 models show positively 
charged S2 and S3 subsites, which can explain the ability of these 
enzymes to accommodate long acidic chains such as lateral polyglu-
tamylation (Figure 1C).
The overlap of the structural models of hCCP3 and hCCP2 shows 
that the main determinants of substrate binding are conserved 
(Figure 1D and Supplemental Figure S1B), and sequence align-
ments extend these conclusions to the entire murine and human 
CCP family (Supplemental Figure S1, B and C). Thus the structure of 
the active site of CCPs reveals that the entire family has a preference 
for cleaving acidic amino acids. The modeling further helped us to 
determine the controversial identity of the specificity-determining 
residue corresponding to position 255 of bovine CPA in the CCPs 
(Kalinina et al., 2007; Rodriguez de la Vega et al., 2007) as being 
arginine (Figure 1A).
CCP2 and CCP3 generate Δ2-tubulin in cells
Deglutamylation can occur on the C-terminally exposed, gene-en-
coded glutamate residues of proteins, such as detyrosinated tubulin 
and myosin light-chain kinase (MLCK), or on posttranslationally 
added polyglutamate chains. This activity was demonstrated for 
CCP1, CCP4, and CCP6; however, no activity had been detected for 
CCP2 and CCP3 (Rogowski et al., 2010). One of the potential rea-
sons for the absence of measurable activity of these two enzymes 
was the difficulty of expressing these proteins in cell lines. To over-
come this problem, we included a synthetic, codon-optimized cDNA 
of mouse CCP3 (Uniprot Q8CDP0-1), as well as a short human CCP3 
isoform (Uniprot Q8NEM8-2), in our study, and we expressed yellow 
fluorescent protein (YFP)/green fluorescent protein (GFP) fusion pro-
teins in HEK293T cells for 40 h instead of 24 h to increase expression 
levels.
in Bornens, 2012) and axonemes, which are the backbones of cilia 
and flagella (reviewed in Jana et al., 2014).
Considering the huge variety of MT functions, the targeting of 
distinct MTs for precisely defined roles in cells appears primordial. 
Functionally distinct MT species can be generated by either incor-
porating selected tubulin isotypes into the MT lattice (reviewed in 
Ludueña and Banerjee, 2008) or generating posttranslational modi-
fications (PTMs) onto selected MTs in cells (reviewed in Janke and 
Bulinski, 2011). Most of the known PTMs of tubulin take place at the 
C-terminal tails of tubulins, which are the key interaction sites for 
microtubule-associated proteins (MAPs) and motors (Sirajuddin 
et al., 2014). PTMs of these tails include polyglutamylation (Eddé 
et al., 1990), polyglycylation (Redeker et al., 1994), detyrosination/
tyrosination (Arce et al., 1975; Hallak et al., 1977; Thompson, 1977), 
and generation of Δ2-tubulin (Paturle-Lafanechère et al., 1991).
Enzymes catalyzing polyglutamylation, polyglycylation, and tyro-
sination are members of the tubulin tyrosine ligase–like (TTLL) family 
(Ersfeld et al., 1993; Janke et al., 2005; Ikegami et al., 2006; Ikegami 
and Setou, 2009; van Dijk et al., 2007; Wloga et al., 2008; Rogowski 
et al., 2009). So far, only deglutamylases have been identified in the 
family of cytosolic carboxypeptidases (CCPs), a subfamily of M14 
metallocarboxypeptidases (Kalinina et al., 2007; Rodriguez de la 
Vega et al., 2007; Kimura et al., 2010; Rogowski et al., 2010). Four 
of six mammalian CCP enzymes catalyze deglutamylation and 
Δ2-tubulin generation; however, the function of the remaining two 
enzymes has remained elusive (Rogowski et al., 2010; Berezniuk 
et al., 2013). Of importance, not only tubulin is modified by CCPs; 
some proteins with gene-encoded acidic C-terminals appear to be 
cleaved in vivo, such as myosin light-chain kinase and telokin 
(Rogowski et al., 2010).
Using structural modeling and enzymatic assays, we find that 
CCP2 and CCP3 are carboxypeptidases that specifically hydrolyze 
acidic amino acids. We further characterize the activities of these 
enzymes with chimeric substrates, and through the study of the in-
dividual knockout and double-knockout mice. Our work on CCP2 
and CCP3 completes the functional characterization of the CCP 
family and suggests an important functional role of this enzyme fam-
ily in posttranslational protein regulation. Moreover, our study dem-
onstrates that the as-yet-undiscovered tubulin-modifying enzymes 
for deglycylation and detyrosination are not found within the CCP 
family.
RESULTS
Prediction of substrate specificities for CCP2 and CCP3
After the discovery that four (CCP1, CCP4, CCP5, CCP6) of the six 
murine CCPs are deglutamylases (Rogowski et al., 2010), attention 
turned to the potential functions of CCP2 and CCP3. Considering 
that enzymes for deglycylation and detyrosination of tubulin have 
not been identified so far and that the reverse enzymes for these 
two reactions are all members of the same TTLL family, one expecta-
tion was that CCP2 and CCP3 could be involved in either or both of 
these PTMs. Indeed, an initial report (Sahab et al., 2011) attributed 
a detyrosinating activity to CCP2; however, unambiguous evidence 
for this activity was not provided, and overexpression of CCP2 did 
not lead to a strong increase in detyrosinated tubulin. To gain more 
insight into the substrate preferences of CCP2 and CCP3, we mod-
eled the catalytic domains of the two enzymes based on the CCP 
crystal structures of Pseudomonas aeruginosa (PDB 4a37; Otero 
et al., 2012), Burkholderia mallei (PDB 3k2k), and Shewanella deni-
trificans (PDB 3l2n; Figure 1A and Supplemental Figure S1A).
The pockets or subsites of the carboxypeptidases, which are 
the binding sites of their substrates, are usually designated using 
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that the 73-kDa human CCP3 isoform we used was shorter than 
the 116-kDa murine CCP3 and thus might be more active in cells, 
analogous to what we previously observed for truncated glutamy-
lase enzymes from the TTLL family (van Dijk et al., 2007; Rogowski 
et al., 2009).
We thus generated a series of truncated forms of murine CCP2 
and CCP3 in order to determine the minimal active size of these 
enzymes (Supplemental Table S1). The YFP-tagged truncated forms 
were expressed in HEK293T cells, and their activity was assessed by 
immunoblot for Δ2-tubulin (Supplemental Figure S2, A and B). 
After 40 h of expression, the cells were lysed and protein ex-
tracts analyzed by immunoblotting. As expected, CCP6 and CCP1 
overexpression led to a marked increase in Δ2-tubulin, pointing to 
them as the most active deglutamylases (Δ2-tubulin is barely de-
tectable in these cells, and thus increased levels indicate deglu-
tamylating activity; Figure 1E). A very weak signal of Δ2-tubulin 
was detected after overexpression of CCP2, but no clear Δ2-tubu-
lin signal was seen after expression of full-length, codon-optimized 
murine CCP3. Strikingly, human CCP3 generated a slight increase 
in the Δ2-tubulin signal (Figure 1E). The simplest explanation is 
FIGURE 1: Structural modeling of the carboxypeptidase domains of CCP2 and CCP3. (A) Modeled structure of human 
CCP3 (as a convention, all residues are numbered according to the corresponding active-site residues in bovine 
carboxypeptidase A1 after propeptide cleavage). The catalytic E270, the main substrate-specificity determining R255, 
and putative secondary binding-site residues are indicated. (B) Scheme of the substrate-binding subsites in the active 
site of carboxypeptidases (Schechter and Berger, 1967). (C) Vacuum electrostatics surface representation of the active 
site of hCCP3. Basic residues are indicated in blue and acidic residues in red. Positions 198 and 201 (corresponding to 
H462 and K465 in hCCP3) shape the S1 binding site in the hCCP3 model. Positions 127 and 145 (R414 and R424 in 
hCCP3) define the S2 subsite. Position 200 (R464 in hCCP3) is oriented toward the outer part of the active site, possibly 
defining an additional, positively charged S3 subsite. Note that although S1′ is defined by different residues 
(Supplemental Figure S1B), we here only depicted positions 250 and 255 because they are the major determinants of 
substrate specificity for CCPs. (D) Overlapped model structures of hCCP2 (cyan) and hCCP3 (green) demonstrate the 
conserved positions in the active-site residues (key residues E270 and R255 are shown). (E) Immunoblots of extracts of 
HEK293T cells expressing YFP-tagged murine and human CCP proteins. Expression of YFP-CCPs was analyzed with 
anti-GFP, and deglutamylating activity was visualized with anti–Δ2-tubulin labeling on endogenous α-tubulin. α-Tubulin 
levels were controlled with 12G10 antibody. mCCP3_opt is a codon-optimized synthetic gene construct; hCCP3 is the 
human 73-kDa isoform of CCP3 (Q8NEM8-2 Uniprot). Note the presence of a specific degradation product (*) of 
mCCP1. Images of structures in A, C, and D were generated with PyMOL 1.3. (–), control without transfection.
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Indeed, the truncated versions of both murine CCP2 and CCP3 
showed a clear Δ2-tubulin–generating activity, demonstrating that 
both can act as deglutamylating enzymes. The shortest and most 
active versions are CCP2_Z1703 and CCP3_Z1670 (Figure 2A), 
which were obtained by truncating nonconserved N- and C-terminal 
sequences to obtain 65-kDa proteins that were similar in size and 
domain structure to the highly active deglutamylase CCP6 (Figure 
2B and Supplemental Figure S2). Immunocytochemical analysis of 
HEK293T cells expressing CCP2 and CCP3 further showed a spe-
cific Δ2-tubulin labeling associated with the MTs in YFP-positive cells 
(Figure 2C). To demonstrate that the observed Δ2-tubulin genera-
tion after CCP2 and CCP3 expression is directly catalyzed by their 
active carboxypeptidase (CP) domains, we generated enzymatically 
dead versions by mutating the essential catalytic residues Glu-593 
in mouse CCP2 and Glu-540 in mouse CCP3 (Glu-270 in bovine CPA 
and Glu-1094 in mouse CCP1; Wu et al., 2012). Enzymatically dead 
mutants of full-length and truncated versions of CCP2 and CCP3 
were expressed at similar levels as the active forms but did not gen-
erate Δ2-tubulin (Figure 2B). Strikingly, a very faint Δ2-tubulin band 
present in the control cells is now absent in the cells overexpressing 
the enzymatically dead enzymes (Figure 2B), suggesting that these 
enzymes can act as dominant negative competitors for endogenous 
enzymes. These experiments demonstrate that the enzymatic activ-
ity of CCP2 and CCP3 is involved in the observed deglutamylation 
reactions on tubulin, leading to Δ2-tubulin.
CCP2 was previously suggested to have a detyrosinating activity 
(Sahab et al., 2011). Although comparison of active sites of CCPs 
with CPA, an enzyme that specifically hydrolyzes Tyr from C-terminal 
positions (Argaraña et al., 1980), strongly suggested that CCPs can-
not catalyze Tyr hydrolysis (Figure 1), we still tested this possibility 
experimentally. We used the detyr-tubulin antibody to specifically 
detect the generation of detyrosinated tubulin in HEK293T cell ex-
tracts overexpressing the optimized forms of CCP2 and CCP3. No 
detectable differences were observed in detyrosinated tubulin, 
whereas the increase of Δ2-tubulin signal clearly indicated the activ-
ity of the overexpressed enzymes (Figure 2B). Thus CCP2 and CCP3 
are not involved in the detyrosination of tubulin, and the identity of 
FIGURE 2: Optimized forms of mCCP2 and mCCP3 reveal 
deglutamylating activity. (A) Scheme of generic CCP; full-length and 
truncated forms of mCCP2 and mCCP3, and the 73-kDa hCCP3 
isoform. The green boxes indicate in the conserved N-terminal 
domain (Nt) specific to CCPs, with FESGNL, WYYY, and YPYTY 
conserved motifs (Rodriguez de la Vega et al, 2007). The blue box 
shows the conserved carboxypeptidase domain (CP) with the catalytic 
residue E270 (E-cat). Gray lines are nonconserved sequences that 
were partially truncated in the optimization. The shortest truncated 
versions that are still enzymatically active are mCCP2_Z1703 and 
mCCP3_Z1670 (red boxes). They are shown in comparison to the 
full-length versions and to hCCP3 (orange box). (B) Immunoblot of cell 
extracts from HEK293T cells expressing YFP-tagged, full-length 
mCCP2 and mCCP3, their optimized truncated forms (A), and 
enzymatically dead versions as controls. Δ2-Tubulin was used 
as readout for deglutamylating activity. Detyrosination 
and deglutamylase activities were followed by generation of 
deTyr- and Δ2-tubulin. Active enzymes generate Δ2-tubulin. 
(C) Immunocytochemistry of HEK293T cells transfected with active 
and inactive truncated YFP-tagged mCCP2 and mCCP3, as well as 
with GFP-mCCP1. After fixation of the cells with a protocol preserving 
microtubule structures (Bell and Safiejko-Mroczka, 1995), Δ2-tubulin 
was detected. Images were collected on an inverted confocal 
microscope (Leica SP5; Leica, Wetzlar, Germany) using a 63× objective 
at 25ºC and analyzed with LAF AS Lite 1.8.1 (Leica). Scale bar, 20 μm.
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more complex organisms, which is also underlined by the greater 
number of CCP genes in mice and humans than in D. melanogaster 
and C. elegans. Finally, it is not clear whether deaspartylation activ-
ity can be found in the last two invertebrates, as clear homologues 
of CCP3 have not been identified. It thus appears that the discovery 
of a deaspartylating activity could have a significant impact on the 
functional reach of C-terminal degradation and offer novel evolu-
tionary insight into the development of this PTM.
Glycylation is a posttranslational modification similar to polyglu-
tamylation, performed by members of the TTLL family (Rogowski 
et al., 2009). Nothing is known about the enzymes responsible for 
shortening or removing posttranslationally generated glycine chains 
from tubulin. The unique deglycylase identified so far is an M20 
peptidase family member in Giardia duodenalis (Lalle et al., 2011). 
Because this enzyme deglycylates the 14-3-3 proteins, and because 
M20 peptidases are not found in the mammalian genome, other 
candidates were considered as potential deglyclases in mammals, 
among them CCP2 and CCP3. Glycylation is typically enriched on 
the axonemes of motile cilia and flagella (Redeker et al., 1994). Thus 
the presence of CCP2 and CCP3 genes in ciliated organisms 
(Rodríguez de la Vega Otazo et al., 2013) and their increased ex-
pression levels in mouse tissues with motile cilia such as testis and 
trachea (Figure 4A) provided a potential link to glycylation. Although 
the structural model already suggested that both enzymes are rather 
specific to acidic amino acids (Figure 1), we wanted to obtain addi-
tional experimental proof to confirm this. Our attempts to directly 
test deglycylating activity in cells with glycylated MTs, which could 
be generated by expression of glycylating enzymes, failed due to 
the toxicity of this treatment for the cells. Thus we developed an 
alternative test for deglycylating activity, in which we coexpressed a 
chimeric telokin containing four Gly residues on the very C-terminus. 
This construct is specifically detected with the polyclonal antibody 
polyG, and removal of only one Gly residue completely abolished 
detection (Supplemental Figure S3B). The chimeric telokin-Gly was 
coexpressed together with CCP2_Z1703 or CCP3_Z1670, and a 
similar experiment was performed with a polyE antibody and a te-
lokin with three Glu residues as positive control (Supplemental 
Figure S3C). Whereas both CCP2_Z1703 and CCP3_Z1670 were 
perfectly able to remove C-terminal glutamates, the unchanged 
polyG signals strongly suggest that C-terminally located Gly resi-
dues cannot be hydrolyzed by these enzymes. Thus CCP2 and CCP3 
do not carry an intrinsic deglycylase activity.
Expression and potential functional roles of CCP2 
and CCP3 in ciliated cells
Having demonstrated that all members of the CCP family are deglu-
tamylating enzymes, we wanted to gain more insight into their spe-
cific functions on the whole-organism level. We thus quantified the 
relative expression levels of all six CCP family members by quantita-
tive real-time-PCR (qRT-PCR) with cDNA samples prepared from a 
representative range of organs. Although qRT-PCR data are semi-
quantitative, it was obvious that both CCP2 and CCP3 are expressed 
at relatively low levels in most organs (Figure 4A), especially when 
compared with CCP1 (Supplemental Figure S4A). CCP4, in contrast, 
was barely detectable in a range of organs, suggesting a very spe-
cialized function in the subgroup of organs where it is expressed 
(Supplemental Figure S4A). The expression profiles of CCP2 and 
CCP3 are highly similar; both enzymes are predominantly found in 
the testis, trachea, and lung, all tissues containing cells with motile 
cilia (Figure 4A). In two tissues, retina and adipose tissue, CCP3 was 
relatively strongly expressed, whereas CCP2 was barely detected 
(Figure 4A; Kalinina et al., 2007).
these long-sought enzymes (Argaraña et al., 1978) remains a 
conundrum.
Enzymatic specificities of CCP2 and CCP3
To further characterize whether CCP2 and CCP3 can remove subse-
quent glutamate residues from longer stretches of glutamates, such 
as those generated by enzymatic polyglutamylation (Audebert et al., 
1993; van Dijk et al., 2007) or genetically encoded as in the case of 
MLCK, we used C-terminally engineered chimeras of telokin, a short 
version of MLCK, which is one of the few known substrates of CCP1 
(Rogowski et al., 2010). Truncated active versions of CCP2 and CCP3 
were coexpressed in HEK293T cells together with different C-terminal 
variants of YFP-telokin. The deglutamylation (removal for long gluta-
mate chains) was monitored using the polyE antibody in immunoblot 
analysis (Shang, 2002), and the final deglutamylation product (ending 
with only one glutamate) was detected with the anti–Δ2-tubulin anti-
body (Figure 3A). Both CCP2_Z1703 and CCP3_Z1670 were able to 
trim long (7-Glu) and shorter polyglutamate chains from the C-termi-
nus of chimeric telokin, as shown by decreased polyE signals and in-
creased Δ2-tubulin immunoreactivity (Figure 3B). CCP1, known to 
shorten long glutamate chains, was used as positive control.
According to the predictions from the molecular modeling 
(Figure 1), any negatively charged amino acid would be susceptible 
to be cleaved by CCPs, not only glutamic acids. However, the previ-
ously tested CCP1, CCP4, and CCP6 where shown to specifically 
remove glutamate in the conditions applied previously (Rogowski 
et al., 2010). To test the specificity of CCP2 and CCP3, we coex-
pressed them with telokin variants exposing either one or two aspar-
tic acids at their C-termini. CCP1 and CCP2 generated weak anti–
Δ2-tubulin–reactive bands at ∼55 kDa, indicative of a cleavage of 
aspartate; however, much stronger Δ2 signals were obtained when 
chimeric telokins with C-terminal glutamates were expressed (Figure 
3B and Supplemental Figure S3A). In contrast to CCP1 and CCP2, 
CCP3 converted both aspartate- and glutamate-ending telokin vari-
ants to their Δ2 form, and as judged from the intensity of the Δ2 
signal, with a similar preference (Figure 3B and Supplemental Figure 
S3A). It is most likely that the weak Δ2 signal generated from telokin-
Asp by CCP1 and CCP2 shows that these two enzymes can cleave 
aspartate; however, this activity might require high enzyme concen-
trations, as even after 40 h of overexpression it was less efficient 
than glutamate hydrolysis. In cells in which endogenous levels of 
CCP1 and CCP2 are much lower than with the overexpression situ-
ation, both enzymes might preferentially or even exclusively hydro-
lyze glutamate. In contrast, CCP3 shows no obvious enzymatic pref-
erence for either glutamate or aspartate removal and might thus be 
involved in protein deaspartylation in cells.
To check the potential effect of the novel enzymatic activity on 
the functional broadness of enzymatic C-terminal degradation of 
proteins on a proteome level, we compared the number of proteins 
with C-terminal poly-Glu stretches, which can be substrates of de-
glutamylases (Rogowski et al., 2010), with the number of acidic 
C-terminal tails including Asp residues. We restricted our analysis to 
the four very well annotated proteomes of Homo sapiens, Mus 
musculus, Drosophila melanogaster, and Caenorhabditis elegans. 
Three main conclusions can be drawn from the numbers we ob-
tained (Figure 3C and Supplemental Table S3). First, the presence of 
a putative deaspartylating activity (CCP3 and possibly other CCPs 
under specific conditions) strongly increases the number of proteins 
that could be C-terminally modified by the CCP family. Second, the 
number of proteins with acidic C-terminal stretches is much higher 
in the mouse and human than in D. melanogaster and C. elegans. 
This could indicate a greater need for this regulatory mechanism in 
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FIGURE 3: Substrate specificity of mCCP2 and mCCP3. (A) Schematic representation of the experimental setup. PolyE 
antibody recognizes telokin constructs with three or more consecutive C-terminal glutamate residues, whereas anti-Δ2-
tubulin antibody detects specifically the C-terminal –GE epitope. C-terminal degradation is detected by generation 
of the Δ2-tubulin epitope, and absence or strong decrease of the polyE signal on telokin (Rogowski et al, 2010). 
(B) Immunoblot analysis of HEK293T extracts after coexpression of different YFP-CCPs and YFP-telokin variants. Activity 
is monitored as shown in A. The activity of truncated mCCP2 and mCCP3 (Figure 2A) is tested with telokin variants with 
different numbers of consecutive glutamate residues to test processivity and with an aspartate residue to test specificity. 
The activities are compared with mCCP1, an established deglutamylase (Rogowski et al, 2010), and a dead version of 
mCCP3 as negative control. Note that only mCCP3 removes aspartate efficiently. (C) Bioinformatic analysis of the 
number of proteins with uninterrupted C-terminal acid sequence stretches. Each column represents the total number of 
proteins per category (mixed Asp and Glu stretches), and the darker insets represent uninterrupted Glu stretches.
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FIGURE 4: Analysis of mCCP2 and mCCP3 expression and of the Agbl2/Agbl3 double-KO mice. (A) Relative expression 
levels of mCCP2 and mCCP3 in different organs of wild-type (WT) mice as determined by qRT-PCR. Average values 
relative to the Tbp gene expression are represented, and error bars represent SD of five independent experiments. 
(B) Cumulative view of the relative expression levels of all six CCP genes in different murine tissues (values from A and 
Supplemental Figure S4A). (C) qRT-PCR analysis of expression levels of all six CCP genes during ciliogenesis in cultured 
IMCD3 cells. Cells were serum starved and analyzed at 0, 3, and 5 d after starvation. Mean values of expression levels 
relative to Tbp expression and relative to 0 d from three to five independent experiments are shown; error bars show 
SD. Two-way analysis of variance was used to determine significance levels (**p < 0.01; ***p < 0.001). (D) Comparative 
immunoblot analysis of protein extracts from different organs of WT and Agbl2/Agbl3 double-KO mice with polyE. Total 
tubulin levels were detected with anti–α-tubulin antibody (12G10). For sperm that showed the highest polyE levels in 
the tubulin region, the experiment was repeated with half of the initial protein load (lanes labeled with *). 
(E) Quantitative analysis of the polyE signal relative to the 12G10 signal Agbl2/Agbl3 double-KO mice relative to WT. 
Four of each WT and double KO were analyzed (Supplemental Figure S5), and relative values were plotted (WT was set 
to 1); error bars show SD. Student’s t test was used to determine significance levels (*p < 0.05; **p < 0.01).
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the discovery of enzymes involved in polyglutamylation, polyglycy-
lation, or detyrosination/tyrosination have opened new opportuni-
ties for mechanistic and functional studies. Amino acid ligases for 
Glu, Gly, or Tyr have been identified in the conserved TTLL family. 
Enzymes removing Glu residues from protein C-termini were found 
within the newly discovered CCP family (reviewed in Janke and 
Bulinski, 2011). Initially, these discoveries raised hopes that the re-
maining enzymes, such as detyrosinases or deglycylases, are also 
members of the CCP family (Sahab et al., 2011). The goal of the 
present study was to determine unambiguously the enzymatic spec-
ificity of the remaining two members of the mammalian CCP family, 
CCP2 and CCP3.
The reason that CCP2 and CCP3 had not been analyzed with the 
same rigorousness as the other members of the family (Rogowski 
et al., 2010) was mainly related to the difficulties in expressing these 
proteins, which hampered the development of enzymatic assays. 
The availability of the crystal structure of a CCP (Otero et al., 2012) 
allowed us to generate a structural model of CCP2 and CCP3, on 
the basis of which we predicted the acidic substrate specificity of 
these two enzymes. Guided by these predictions and optimizing the 
coding sequences of CCP2 and CCP3 led us to the demonstration 
that both enzymes are consistent with C-terminal deglutamylation 
activity on proteins, similar to the family members CCP1, CCP4, and 
CCP6 (Rogowski et al., 2010). On the level of MTs, CCP2 and CCP3 
can generate Δ2-tubulin, and their ability to shorten long Glu chains 
also allows them to deglutamylate laterally polyglutamylated tubu-
lin. Δ2-Tubulin, as well as polyglutamylated forms of tubulin, is 
specifically accumulated on neuronal, centriolar, ciliary, and flagellar 
MTs (Paturle-Lafanechère et al., 1994; Ikegami and Sato, 2010; 
Vogel et al., 2010; Bosch Grau et al., 2013). Thus the specific 
expression of CCP2 and CCP3 in ciliated tissues, as well as the 
increase of their expression levels during ciliogenesis, suggest that 
they fulfill specific functions in the regulation of the two PTMs in 
these organelles. Indeed, we showed that double knockout of both 
enzymes in mice results in significant changes in tubulin polyglu-
tamylation in testes and sperm, which is consistent with the rela-
tively high expression levels of CCP2 and CCP3 in testes. However, 
similar changes could not be visualized in other ciliated tissues of 
these mice.
Our results show that CCP2 and CCP3 participate in the process 
of deglutamylation; however, other enzymes, such as CCP1, CCP4, 
and CCP6, are also involved and might in most cases compensate 
for the absence of these two enzymes. It is thus possible that CCP2 
and CCP3 play some highly regulated, specific roles in adjusting 
tubulin modifications locally or temporally in most cells and organs. 
This could be important for fine-tuning specific MT functions but 
does not induce global changes visible on the level of the whole 
tubulin pool. The absence of strong phenotypic alterations in Agbl2/
Agbl3 double-KO mice also points toward highly specified func-
tions that might only be revealed under specific conditions, such as 
adaptation to evolutionary pressure or diseases. We recently made 
a similar observation for a member of the TTLL family (Rocha et al., 
2014).
Analyzing the enzymatic activities of CCP3 further revealed that 
this particular enzyme can, besides Glu, also hydrolyze Asp residues 
from C-terminal positions. CCP3 seems to catalyze Glu and Asp re-
moval with equal efficiency, whereas all other enzymes of the CCP 
family show only weak activity for Asp. It might thus be that Asp 
hydrolysis is an important function for CCPs, but apart from CCP3, 
other CCPs require specific cofactors or other regulatory events to 
efficiently catalyze this reaction. The biological effect of this novel 
enzymatic activity could be significant. In addition to modifying 
On comparison of the relative expression levels of the CCP en-
zymes as determined by qRT-PCR, it is obvious that CCP1 is the de-
glutamylase with the highest expression levels and the broadest 
distribution in different tissues (Figure 4B). Although this does not 
allow judging the functional importance of those enzymes, it sug-
gests that CCP1 catalyzes a large share of deglutamylation reactions. 
Indeed, the knockout model for CCP1, the Purkinje cell degenera-
tion (pcd) mouse, shows severe defects related to tubulin hyperglu-
tamylation in several organs (Rogowski et al., 2010). In contrast, 
other CCP enzymes might have more specialized functions in spe-
cific cells, organelles, or even on some selected MTs within cells.
The elevated expression levels of CCP2 and CCP3 in ciliated tis-
sues containing axonemes, such as the testis, lung, and trachea, 
suggest a potential role of these enzymes in the assembly or func-
tion of cilia. To investigate this link, we quantified the expression of 
all six CCPs during ciliogenesis in IMCD3 cells in culture by qRT-PCR 
at 0, 3, and 5 d after induction of ciliogenesis by serum starvation. 
Apart from CCP4, all other CCPs could be detected, but only CCP2 
and CCP3 show a statistically significant increase of expression lev-
els during ciliogenesis (Figure 4C). Thus several enzymes of the 
deglutamylase family are likely to be involved in ciliary outgrowth, 
maintenance, and function, consistent with the importance of glu-
tamylation in cilia assembly and function (Bosch Grau et al., 2013; 
Pathak et al., 2014); however, CCP2 and CCP3 are likely to play 
highly specific role in these processes.
The similar expression profiles of CCP2 and CCP3 determined by 
qRT-PCR and previously by in situ hybridization (Rodríguez de la 
Vega Otazo et al., 2013) suggest some functional overlap of these 
two enzymes. Because the individual knockout (KO) mouse models 
for CCP2 (Agbl2 [ATP/GTP binding protein–like]) and CCP3 (Agbl3) 
are both fertile, we generated double (Agbl2/Agbl3) KO mice. These 
mice were viable and displayed no obvious phenotypic alterations. 
To study the potential change in polyglutamylation levels on tubulin 
and other proteins, we dissected selected organs, prepared tissue 
extracts, and analyzed them with polyE antibody in immuno blot 
(Figure 4D and Supplemental Figures S4B and S5). Compared to 
wild-type mice, tubulin polyglutamylation was increased in the tes-
tes and sperm of the Agbl2/Agbl3 double-knockout mice (Figure 4E 
and Supplemental Figure S5). Apart from testes and sperm, no other 
organ showed detectable changes in tubulin polyglutamylation lev-
els in Agbl2/Agbl3 KO mice (Figures 4D). In addition to tubulin, 
polyE immunoreactivity of a 130-kDa protein was increased in sperm 
of a 5-wk-old Agbl2/Agbl3 KO mice; however, this band was not 
detected in the 4-mo-old mice. In the previous analysis of the pcd 
mouse, the 130-kDa substrate was identified as MLCK1, of which the 
C-terminal glutamate stretch is detected with polyE (Rogowski et al., 
2010). Our observations in the Agbl2/Agbl3 KO mice indicate that 
CCP2 and CCP3 are complementarily involved in the deglutamyla-
tion of MLCK1 in sperm, but that other enzymes could compensate 
for the absence of these two enzymes in adult mice (Figure 4D and 
Supplemental Figure S5). A similar increase in polyE immunoreactiv-
ity of MLCK1 was observed in stomach of the Agbl2 KO mice, as well 
as in stomach and oviduct of the Agbl3 KO mice (Supplemental 
Figure S4B). These data show that in certain organs, CCP2, CCP3, 
or both enzymes are involved in the deglutamylation of MLCK1 
(Supplemental Figure S4B and 4D). However, no visible phenotype 
has been related to this change in deglutamylation in these mice, 
perhaps due to compensation during development.
DISCUSSION
Protein PTMs consisting of the ligation or hydrolysis of amino acids 
have recently been attributed an increasing range of functions, and 
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structures was applied (Bell and Safiejko-Mroczka, 1995). In brief, 
cells were incubated 10 min at room temperature in 1 mM 
dithiobis(succinimidyl propionate) (DSP; Thermo Scientific, Rockford, 
IL) in Hanks’ balanced salt solution, followed by 10 min of incubation 
with 1 mM DSP in microtubule-stabilizing buffer (MTSB). Cells were 
washed in phosphate-buffered saline (PBS) for 5 min with 0.5% 
Triton X-100 (Fluka, Saint-Quentin Fallavier, France) in MTSB before 
fixation with 4% paraformaldehyde (PFA) in MTBS. This step was 
followed by a 5-min wash in PBS, 5 min in 100 mM glycine in PBS, 
and a final wash in PBS.
After fixation, cells were washed for 5 min in PBS containing 0.1% 
Triton X-100 and then incubated with primary antibodies in PBS, 
0.1% Triton X-100, and 2% bovine serum albumin (Sigma-Aldrich, 
Villebon sur Yvette, France) for 1 h at room temperature. Next cells 
were washed four times with PBS and 0.1% Triton X-100, followed by 
1-h incubation with anti–rabbit Alexa Fluor 568 and anti–mouse Alexa 
Fluor 350 (Invitrogen, Saint Aubin, France) in PBS and 0.1% Triton 
X-100. Washes were performed before coverslips were mounted with 
ProLong Gold (Life Technologies, Saint Aubin, France).
RNA extraction and quantitative PCR
Organs were dissected from 4- to 5-wk-old mice and immediately 
frozen in liquid nitrogen. IMCD3 cells were maintained under stan-
dard conditions and serum starved for 3 and 5 d to induce ciliogen-
esis. RNA extraction was performed using TRIzol reagent (Life 
Technologies), following manufacturer’s instructions. The RNA con-
centration and quality was determined, and qRT-PCR was applied 
under standard conditions using the SYBR Green Master Mix kit on 
the ABI Prism 7900 Sequence Detection System (PerkinElmer-
Cetus, Courtaboeuf, France) using specific primers (Supplemental 
Table S4).
Search in the database for proteins ending with acidic 
amino acidic stretches
A bioinformatic search for proteins susceptible to be substrates of 
CCPs was performed using ScanProsite tool (de Castro et al., 2006). 
The search for total acidic proteins was performed using the pattern 
[ED](n)>, where n represents the number of consecutive acidic resi-
dues at the protein’s C-terminus. We searched for C-terminal 
stretches from two and longer. The total number of proteins with a 
given number of acidic amino acids at the C-terminus was deter-
mined from the H. sapiens, M. musculus, D. melanogaster, and 
C. elegans taxons of the 2014_05 UniProtKB/Swiss-Prot database, 
using the default settings. Splice variants were not allowed. The 
same search was repeated for C-terminal tails containing only gluta-
mate residues.
Generation of Agbl2 KO, Agbl3 KO, and Agbl2/Agbl3 
double-KO mice
The conditional mutant mouse lines for Agbl2 (on exon 9) and for 
Agbl3 (on exons 7 + 8) were established at the Mouse Clinical Insti-
tute (MCI, Illkirch, France). The targeting vector was constructed as 
follows. The 5′ (4.5 kb for Agbl2; 3.5 kb for Agbl3), 3′ (3.5 kb for 
CCP2; 4.7 kb for CCP3), and inter-loxP (1.1 kb for Agbl2; 3.0 kb for 
Agbl3) fragments were PCR amplified and sequentially subcloned 
into an MCI proprietary vector containing the LoxP sites and a Neo 
cassette flanked by Flippase Recognition Target sites (Supplemental 
Figure S6). The linearized construct was electroporated in 129S2/
SvPas mouse embryonic stem (ES) cells. After selection, targeted 
clones were identified by PCR using external primers and further 
confirmed by Southern blot with 5′ and 3′ external probes. Two 
positive ES clones were injected into blastocysts, and derived male 
proteins with C-terminally exposed Glu residues, such as MLCK1 or 
telokin (Rogowski et al., 2010), we now envisage differential C-ter-
minal modification of a larger range of potential substrates. The 
possibility to selectively remove the Glu and the Asp residues by 
different CCPs opens the possibility that this novel PTM has a 
broader effect on protein functions than initially expected from de-
glutamylation alone. Still, the absence of striking phenotypic altera-
tions of the Agbl3 (CCP3) knockout mouse indicates that these 
modifications can be redundantly performed or have only fine-reg-
ulatory roles that remain to be discovered.
In summary, we showed that all members of the murine CCP 
family are involved in protein deglutamylation, and we further dis-
covered a novel deaspartylating activity for CCP3. Our functional 
analyses suggest that CCP2 and CCP3 fulfill complementary func-
tions in regulating protein glutamylation in ciliated cells and tissues. 
Strikingly, the deletion of both enzymes in mice did not impede key 
organism functions, which indicates that, similar to other enzymes 
involved in this type of PTM, the two CCPs might play roles in fine-
tuning protein functions. The analysis of the enzymatic activities of 
CCP2 and CCP3 completes the repertoire of enzymes involved in 
ligation and removal of acidic amino acids on proteins. The discov-
ery of a novel Asp-hydrolyzing activity further expands the complex-
ity of this type of PTM, broadens the range of potential substrates, 
and points toward novel functions of the CCP enzyme family.
MATERIALS AND METHODS
Structural alignment
The catalytic domain of CCP3 was modeled with the help of the 
RaptorX server (Källberg et al., 2012) and using as templates the 
available structures of three CCPs from P. aeruginosa (PDB 4a37; 
Otero et al., 2012), B. mallei (PDB 3k2k), and S. denitrificans (PDB 
3l2n). Ramachandran plots were derived for the proposed models 
to verify proper stereochemistry of the residues, and local and over-
all model quality was verified using Verify3D (Bowie et al., 1990; 
Luthy et al., 1992) and Prosa-web (Sippl, 1993; Wiederstein and 
Sippl, 2007). Arg at position 255 was supported by the structure-
based sequence alignment performed by RaptorX, I-TASSER (Zhang, 
2008; Roy et al., 2010), GalaxyWEB (Ko et al., 2012), and PDBsum 
(Laskowski, 2001; unpublished data).
Cell culturing, transfection, and immunoblotting
Adherent HEK293T cells were maintained under standard condi-
tions and transfected (see Supplemental Table S1 for plasmids) 
with linear polyethylenimine (PEI; Polysciences, Eppelheim, 
Germany) in a 1:3 DNA:PEI ratio. Cells were collected after 48 h, 
lysed in 100 mM Tris-HCl, pH 8, 150 mM NaCl, and 0.1% NP-40 
supplemented with 1/1000 of the EDTA-free protease inhibitor 
cocktail Set III (Calbiochem, Darmstadt, Germany), and centrifuged 
for 10 min, 15,000 × g at 4°C. SDS–PAGE and immunoblotting 
onto nitrocellulose membranes (EMD Millipore, Darmstadt, 
Germany) were performed using standard protocols. Proteins were 
detected using different primary antibodies (Supplemental Table 
S2) and visualized with horseradish peroxidase–labeled secondary 
antibodies, followed by chemiluminescence (ECL Western blot de-
tection kit; GE Healthcare, Velizy-Villacoublay, France).
Cell fixation and immunocytochemistry
For immunofluorescence, HEK293T cells were seeded onto culture 
dishes and transfected 24 h after plating, as described before. After 
12 h, cells were trypsinized and plated onto sterile glass coverslips 
in six-well plates (Nunc, Villebon sur Yvette, France) and incubated 
for 24 h before fixation. A fixation method to preserve microtubule 
3026 | O. Tort et al. Molecular Biology of the Cell
chimeras gave germline transmission. The excision of the neomycin-
resistance cassette was performed in vivo by breeding the chimeras 
with a Flp deleter line (C57BL/6N genetic background FLP under 
ACTB promoter). The Flp transgene was segregated by breeding 
the first germline mice with a wild-type C57BL/6N animal. For 
generation of Agbl2 KO and Agbl3 KO mice, Agbl2 and Agbl3 
floxed mice were crossed with transgenic mice expressing Cre re-
combinase under the control of a cytomegalovirus promoter.
The Agbl2/Agbl3 double-KO mice were then generated by 
crossing the single-KO mice. Genomic DNA isolated from mouse-
tail snip was analyzed by PCR.
Mice were genotyped by PCR according to MCI protocols using 
GoTag polymerase (Promega, Charbonnieres, France) and 33 ampli-
fication cycles. The following sets of three primer pairs were used to 
define the genotypes.
For CCP2:
CCP2_Ef: CATCCTTAGCAACTCTCCCGATGCCC, CCP2_Er: 1) 
GGTGGGGGTGTGTGTGAAATGGCTG
CCP2_Lf: CCACGAGCGACCTTCCAAACCTACC, CCP2_Lr: 2) 
AGCTGCCTGCTACAGCAAACGGG
CCP2_Lf: CCACGAGCGACCTTCCAAACCTACC, CCP2_Er: 3) 
GGTGGGGGTGTGTGTGAAATGGCTG
For CCP3:
CCP3_Ef: CCTCAAAACCACTGACCATCTAGACAGCC, CCP3_1) 
Er: GGGCTGGAGTAGACACTGTACATAAGAAAGC
CCP3_Lf: CTGGAGTGGGACTAGTATCTTGAAGATGGG, CCP3_2) 
Lr: CCCCAGGAACTTTGACCCTTTGTGTGC
CCP3_Lf: CTGGAGTGGGACTAGTATCTTGAAGATGGG, CCP3_3) 
Er: GGGCTGGAGTAGACACTGTACATAAGAAAGC
Animal experimentation
Wild-type C57BL/6N, Agbl2 KO, Agbl3 KO, and Agbl2/Agbl3 dou-
ble-KO mice were housed under specific-pathogen-free conditions 
in the animal facility of the Institut Curie. Animals were maintained 
with access to food and water ad libitum in a colony room kept at 
constant temperature (19–22°C) and humidity (40–50%) at 12-h 
light/dark cycles. All experimental procedures were performed in 
strict accordance with the guidelines of the European Community 
(86/609/EEC) and the French National Committee (87/848) for care 
and use of laboratory animals.
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Supplemental figure legends  
Figure S1. Structural alignment of CCPs and determination of amino acids of the active site. A) 
Structural alignment of the catalytic domain of hCCP3 with the CCP crystal structures of 
Pseudomonas aeruginosa (PDB 4a37) (Otero et al., 2012), Burkholderia mallei (PDB 3k2k) and 
Shewanella denitrificans (PDB 3l2n) obtained with the RaptorX server. B) Comparison of the amino 
acids shaping the S1’ binding pocket in different carboxypeptidases with different defined amino-acid 
specificities. Residues are indicated following the RasMol amino color scheme that colors amino acids 
accordingly to their properties. aResidue 207 is the major determinant of specificity for M14B 
carboxypeptidases. bResidue 255 is the major determinant of specificity for M14A carboxypeptidases. 
cCarboxypeptidase isolated from Thermoactinomyces vulgaris that is a model for broad substrate 
specificity. dM14D is the proposed classification for the M14 members that constitute the CCP 
subfamily. C) Amino acid sequence alignment of the region around position 255 of CCPs and 
canonical bovine CPA. The positions known to participate in the binding of the substrate C-terminal 
residue are indicated. 
 
Figure S2. Sequence optimization of active mCCP2 and mCCP3. To confirm that our truncated 65-
kD versions of mCCP2 and mCCP3 (Figure 2A, B) represent the shortest active version of these 
enzymes, we further truncated short sequences at their N- and the C-termini. A) Scheme of full-length 
of mCCP6, mCCP2, mCCP3 and several truncated forms of mCCP2 and mCCP3. The green boxes 
indicate in the conserved N-terminal domain (Nt) specific to CCPs, the blue box is the conserved 
carboxypeptidase domain (CP; compare with Figure 2A). Carboxypeptidase domain schemes were 
delimitated with Superfamily 1.73 database (Gough et al., 2001). Gray lines are non-conserved 
sequences that were partially truncated in the optimization. B) Immunoblot analysis HEK293T cell 
extracts expressing different forms of YFP-mCCP2 and YFP-mCCP3 as shown in (A). The 
deglutamylase activity is monitored by the generation of Δ2-tubulin. 12G10 is used to control -
tubulin loading. C) Secondary structure prediction of an essential C-terminal fragment determined in 
  2 
mCCP2 and mCCP3 performed with Coils server (Lupas et al., 1991). The fragment present in 
mCCP2_Z1703 and mCCP3_Z1670, but deleted in mCCP2_1607 and mCCP3_Z1583 has a high 
probability for coiled-coil structure. Coiled-coil structures are known to participate in structural 
stabilization and oligomerization of proteins (Parry et al., 2008). It is thus possible that the removal of 
these coiled-coil sequences from mCCP2 and mCCP3 resulted in misfolded or destabilized enzymes, 
and consequently in loss-of-activity. Alternatively, it could indicate that both enzymes need to 
oligomerize for activity. 
 
Figure S3. Specificity tests for truncated mCCP2 and mCCP3. Immunoblot analysis of HEK293T 
protein extracts co-expressing truncated forms of YFP-mCCPs and YFP-telokin variants. A) Co-
expression of active or dead truncated forms of YFP-mCCP2 and YFP-mCCP3 together with YFP-
telokin variants ending in different acidic tails to test their ability to release single of multiple Asp 
and/or Glu residues. Generation of the ∆2-tubulin epitope on telokin is used to monitor C-terminal 
degradation. mCCP1 is used as positive control for deglutamylation. Note that only mCCP3-Z1670 is 
efficiently removing single and consecutive Asp residues. See also Figure 3B. B) Epitope mapping of 
polyG antibody on artificial C-terminal tails of YFP-telokin with different numbers of Gly residues. 
Note that only poly-Gly chains of four and longer are recognized by this antibody. (*non-specific band 
recognized by the polyG antibody). C) Schematic representation of the experimental setup used to 
identify deglutamylation and deglycylation activities. YFP-telokin with 3-Glu tails (detected by 
polyE) or 4-Gly tails (detected with polyG) are co-expressed with YFP-CCPs. The immunoblots show 
that truncated versions of YFP-mCCP2 and YFP-mCCP3 efficiently remove C-terminal Glu residues 
thus extinguishing the polyE signal. In contrast, no change in the polyG signal was detected in the 
deglycylation test.  
 
Figure S4. qRT-PCR analyses expression levels of mCCP1, mCCP4, mCCP5 and mCCP6 in 
murine tissues and analysis of Agbl2 and Agbl3 KO mice. A) Relative expression levels of mCCP1, 
mCCP4, mCCP5 and mCCP6 in different organs of 4-month-old wild type mice as determined by 
  3 
qRT-PCR. Average values relative to the Tbp gene expression are represented, and error bars 
represent standard deviation of three to five independent experiments. Experiments are 
complementary to Figure 4A. Values are used for Figure 4B. B) Comparative immunoblot analysis of 
protein extracts from different organs of 5-weeks old wild type (WT) and Agbl2 or Agbl3 KO mice 
with polyE. Total tubulin levels were detected with anti--tubulin antibody (12G10). Note that a 130-
kDa substrate shows increased polyE signals stomach of Agbl2 or Agbl3 KO mice, and in oviduct of 
the Agbl3 KO mouse.  
Figure S5. Analyses of the polyglutamylation levels in Agbl2/Agbl3 double KO mice. A) Immuno 
blots of testes and sperm extracts from four of each, WT and Agbl2/Agbl3 double KO mice (mice 1, 2, 
3, 5, 6 and 7 were 4 months old; mice 4 and 8 were 5 weeks old). The polyE and 12G10 signals as 
represented here have been quantified using the software ImageJ, and polyE values have been adjusted 
to the total tubulin load detected with the antibody 12G10. Mean values have been plotted in Figure 
4E. *Note that the 130-kDa polyE-positive protein band is only detected in the 5-week old mouse 
(which is shown in Figure 4D), but not in the older individuals.  
 
Figure S6. Strategy for the generation of the knockout mice. Schematic representation in scale of 
the targeting vector used and all the possible alleles for Agbl2 and Agbl3 genes. Orange bar: genomic 
DNA. Black boxes: exons with their corresponding number. Green and purple arrowheads: LoxP and 
Flp sequences, respectively. White bar: neo cassette, with the neomycin resistance gene (white box). 
Blue lines: zone of sequence homology for homologous recombination, with the corresponding size in 
kbp. Black arrowheads: primers used for the PCR genotyping. 
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Supplemental Tables  
Table S1. Primers used to clone or mutagenize CCP genes and their truncated forms. 
Gene Vector Primers Fw/Rev 
mCCP1 pcDNA3.1-
EYFP 
Fw: cgcggagtcgacACC ATGAGCAAGCTAAAAGTGGTGGGAGAG 
Rev: cgccgctgatca AATCAGGTGTGTTCTTGATACCTCAG 
mCCP2 pEYFP Fw: cgcggactcgagACC ATGAATGTCCTGCTTGAGATGGCTTTTC 
Rev: cgccgcagatct TGGGTATGTGTATATATGCAAGGATGGG 
mCCP3 pEYFP Fw: cgcggactcgagACC ATGTCAGAAGATTCAGAGGAGGAAGAC 
Rev: cgccgcggatcc CTGATGCTGTTGCAAGTTGGCTATC 
mCCP3_opt pEYFP Synthetic gene optimized for bacterial codon usage (GeneCust). 
hCCP3 pOPINFS from N. Berrow (IRB, Barcelona, Spain) 
mCCP4 pEGFP Fw: cgaattctagccATGGCTGAACAAGAAGGCAGT 
Rev: ctggatccgggagacacagagatgtcac (non coding region) 
mCCP5 pEYFPr Fw: ccgcgactgcagACC ATGGAGCTGCGCTGTGGGGGATTGC 
Rev: ccgcgaggtacc TCCCTCTGCGAGTCGGCGGTGAGC 
mCCP6 pEYFP Fw: cgcggactcgagACC ATGGCGGAGCGGAGCCAGACAGCGCC 
Rev: ccgcagaTCT AAAGGGGGTTGATGGGTCTTTG 
mCCP2_N2190 pEYFP Fw: cgcggactcgagACC ATGAATGTCCTGCTTGAGATGGCTTTTC 
Rev: ccgcggatcc GCTCTTCTGGTACTGCTCATTCCG 
mCCP2_N1992 pEYFP Fw: cgcggactcgagACC ATGAATGTCCTGCTTGAGATGGCTTTTC 
Rev: ccgcggatcc TAAATCCATATCTTGTCCAAAGTTATTC 
mCCP2_Z1703 pEYFP Fw: cggactcgagACC atgGACTCACTTCTGCTGAGCTCGCC 
Rev: ccgcggatcc TAAATCCATATCTTGTCCAAAGTTATTC 
mCCP2_Z1334 pEYFP Fw: cggactcgagACC atgACACTGCAAGGGCCGGACGAC 
Rev: ccgcggatcc TAAATCCATATCTTGTCCAAAGTTATTC 
mCCP2_Z1607 pEYFP Fw: cggactcgagACC atgGACTCACTTCTGCTGAGCTCGCC 
Rev: ccgcggatcc GTCAGGATCACAGAAATCCAG 
mCCP3_N1998 pEYFP Fw: cggactcgagACC ATGAGCGAGGACTCTGAAGAAG 
Rev: ccgcggatcc GTAAACTTCCTGCATATTGTTCTGG 
mCCP3_N1809 pEYFP Fw: cggactcgagACC ATGAGCGAGGACTCTGAAGAAG 
Rev: ccgcggatcc GGTATCCGTGTTATCGGAGACGC 
mCCP3_Z1670 pEYFP Fw: cggactcgagACC atgGACCCGTTTTTCCCACGCACCAC 
Rev: ccgcggatcc GGTATCCGTGTTATCGGAGACGC 
mCCP3_Z1325 pEYFP Fw: cggactcgagACC atgGTGGATAACTGCGACAACACCC 
Rev: ccgcggatcc GGTATCCGTGTTATCGGAGACGC 
mCCP3_Z1583 pEYFP Fw: cggactcgagACC atgGACCCGTTTTTCCCACGCACCAC 
Rev: ccgcggatcc GTCCGGGTCGCAGTAGTCCAG 
mCCP2_E593Q 
(dead version) 
pEYFP Fw: GCTACACCATGcAGTCTACCTTTGGC 
Rev: CAAAGGTAGACTgCATGGTGTAGCTG 
mCCP3_E540Q 
(dead version) 
pEYFP Fw: CTTTCACCCTGcAAGCAACTTTCTGCG 
Rev: GAAAGTTGCTTgCAGGGTGAAAGAATTGC 
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Table S2. Primary antibodies used in this study 
Dilutions 
immuno blot 
Antibody 
name 
Antigen Type 
cell 
lines 
tissue 
extracts 
immuno 
cyto-
chemistry 
Provider 
12G10 -tubulin  mouse 
monoclonal 
1:1,000 1:400 - from J. Frankel, E. M. 
Nelson, University of 
Iowa, USA 
anti--
tubulin 
-tubulin mouse 
monoclonal 
- - 1:200 Sigma #T5201  
anti-Δ2-
tubulin 
CEGEEEGE-
COOH 
rabbit 
polyclonal 
1:5,000 1:5,000 1:1,000 our own production 
anti-deTyr-
tubulin 
-CGEEEGEE-
COOH 
rabbit 
polyclonal 
1:2,000 - - Millipore #AB3201 
polyE -CEEEEEEEEE-
COOH 
rabbit 
polyclonal 
1:4,000 1:10,00
0 
- our own production 
polyG -CGGGGGGGGG-
COOH 
rabbit 
polyclonal 
1:6,000 - - our own production 
anti-GFP GFP, YFP, CFP rabbit 
polyclonal 
1:5,000 - - Torrey Pines Biolabs, 
#TP401 
 
Table S3. Search for C-terminal acidic amino acid stretches 
 Number of proteins with uninterrupted E/D-stretches at the C-terminus  
Organism 2 3 4 5 6+ 
Homo sapiens 287 60 16 12 24 
Mus musculus 218 55 9 4 23 
Drosophila 
melanogaster 47 9 2 3 6 
Caenorhabditis 
elegans 42 14 6 3 4 
 
 
 Number of proteins uninterrupted E-stretches at the C-terminus 
Organism 2 3 4 5 6+ 
Homo sapiens 94 12 1 1 3 
Mus musculus 76 7 1 1 4 
Drosophila 
melanogaster 14 1 0 0 2 
Caenorhabditis 
elegans 16 0 0 0 2 
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Table S4. Primers used for qRT-PCR 
Specificity Gene Primer name Sequence (5’-3’) 
AGTPBP1-U1 TTCCACAGAGTCAGATACTGCCAGAT CCP1 
AGTPBP1-L1 CAGAACTTCCATGCCTGTAGAACCT 
AGBL2-U2 AATCTGCAGAAAGCCGTCAGAGT CCP2 
AGBL2-L2 AGTGTGTTTGTCCGTGTAGAGGTCA 
AGBL3-U1 CTGTTTACCCAAACTCCAAGGAAGAT CCP3 
AGBL3-L1 GGATGTTCGGTTACCCCCAACT 
AGBL1-U2 GAGCTGTCCTGTAGCTTTGAGGAACT CCP4 
AGBL1-L2 AAGCAACACTTGGAATGTGGTGGT 
AGBL5-U2 GCACCCAAAAGGTCAGCCAT CCP5 
AGBL5-L2 GCCGCCTTCTGTCTGAGCA 
AGBL4-U2 CCAAGAGTCTTTACCGAGATGGGAT 
mouse 
CCP6 
AGBL4-L2 CTGTGGTCTGGGCAGCGATAGT 
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CPA1_BOVIN  T-SYKYG-SIITTIYQ--------------ASGGSIDWSYNQ--GIKYSFTFELRDTGR 
CCP1        I-APA-F-CMSSCSFVVEK----------SKESTAR VVVWREIGVQRSYTMESTLCGC 
CCP4        L-APA-F-TMSSCSFLVEK----------SRASTAR-VVVWREMGVSRSYTMESSYCGC 
CCP2        N-APDKF-SFHSCNFKVQK----------CKEGTGR-VVMWR-MGILNSYTMESTFGGS 
CCP3        N-CPDKF-SFSACKFNVQK----------SKEGTGR-VVMWK-MGIRNSFTMEATFCGS 
CCP5        N-SAH-F-DFQGCNFSEKNMYARDRRDGQSKEGSGR-VAIYKASGIIHSYTLECNYNTG 
CCP6        N-AED-F-SYSSTSFNRDA----------VKAGTGRRFLGGLLDHTSYCYTLEVSFYSY
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